arrow
T

Tibor A. Zwimpfer

university of basel
H指数:9
被引数:255

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026

第27届欧洲妇科肿瘤学大会最佳原创研究:ESGO 2026精华

2026-07-110
PRE
Gender and regional equity in the European Society of Gynaecological Oncology: a longitudinal analysis of a professional medical society

欧洲妇科肿瘤学会中的性别与地区公平性:一项专业医学学会的纵向分析

2026-06-130
PRE
Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study “Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer”: The International NOGGO, ENGOT, and GCIG Survey

长期年轻成年卵巢癌幸存者:研究“Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer”的亚组分析:国际NOGGO、ENGOT和GCIG调查

Cancers
IF4.4
2026-04-080
OAAI
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma

BRCA缺陷性输卵管卵巢高级别浆液性癌的生存临床病理及分子预测因子

2026-04-010
OAAI
Urinary incontinence management in patients with primary endometrial cancer: A cross-sectional study by the European Network of Young Gynaecologic Oncologists (ENYGO)

原发性子宫内膜癌患者尿失禁管理:欧洲青年妇科肿瘤学家网络(ENYGO)的一项横断面研究

2026-02-010
PRE
Omission of sentinel lymph node biopsy in early stage luminal breast cancer: impact on adjuvant CDK4/6 inhibitor recommendation and oncological outcomes

早期luminal型乳腺癌中哨兵淋巴结活检的省略:对辅助CDK4/6抑制剂推荐和肿瘤学结局的影响

2025-11-070
OAAI
Best original research presented at the 26th European Congress on Gynaecological Oncology: Best of ESGO 2025

第26届欧洲妇科肿瘤学大会(ESGO 2025)最佳原创研究:ESGO 2025精选

2025-05-090
PRE
Declaration on cervical cancer elimination: literature review and perspectives from early-career clinicians

宫颈癌消除宣言:文献综述及早期职业临床医生的观点

2025-04-260
PRE
Challenges in Surgical Randomized Controlled Trials (RCTS) Gynaecologic Oncology: Insights from a European Network Young Gynae Oncologists (ENYGO) Study

妇科肿瘤学中手术随机对照试验(RCTS)的挑战:来自欧洲网络青年妇科肿瘤学家(ENYGO)研究的见解

2025-02-010
PRE
Efficacy And Safety Of PARP Inhibitor Maintenance In Platinum-Sensitive Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review And Meta-Analysis

PARP抑制剂在铂敏感晚期上皮性卵巢癌中的维持治疗:系统评价与Meta分析

2025-02-010
PRE
Secondary Debulking Followed By Localised Radiotherapy In Patients With Oligometastatic Recurrent Ovarian Cancer-A Case Series Of Two International Cancer Centres

寡转移性复发性卵巢癌患者的二次减瘤术联合局部放射治疗——两家国际癌症中心病例系列研究

2025-02-010
PRE
Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival

输卵管卵巢高级别浆液性癌患者结局的临床与分子预测因子及特殊生存情况

2024-09-010
PRE
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

同时RB1丢失和BRCA缺乏可预测输卵管卵巢高级别浆液性癌的免疫反应增强和长期生存

2024-06-050
OAAI